Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q3 2025 · 10-Q
Revenue$62.84M$62.84M+17.5% vs Q3 2024 Net Income-$1.68M-$1.68MN/M vs Q3 2024 EPS Diluted-$0.31-$0.31N/M vs Q3 2024 Gross Profit$39,754,000+19.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$18,129,000+57.2% Free Cash Flowderived$17,316,000+66.4% Margins · derivedGross margin63.3%+0.8 pt vs Q3 2024
Operating margin9.2%+9.3 pt vs Q3 2024
Net margin-2.7%−6.6 pt vs Q3 2024
ended Dec 31, 2024 · filed Feb 4, 2025 · 35 d after period end